Rapid reduction with cystic transformation of invasive giant prolactinoma following short term low dose cabergoline

Rapid reduction with cystic transformation of invasive giant prolactinoma following short term low dose cabergoline

Bibliographic Details
Main Authors:	Deep Dutta, Sujoy Ghosh, Satinath Mukhopadhyay, Subhankar Chowdhury
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2012-01-01
Series:	Indian Journal of Endocrinology and Metabolism
Online Access:	http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=6;spage=1048;epage=1051;aulast=Dutta

Similar Items

Clinical Outcome of Invasive Pituitary Prolactinomas Treated with Cabergoline
by: Bassam M Flamerz Arkawazi
Published: (2020-01-01)

De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
by: Chayma Belhadj Slimane, et al.
Published: (2023-07-01)

Panhypopituitarism with empty sella a sequel of pituitary hyperplasia due to chronic primary hypothyroidism
by: Deep Dutta, et al.
Published: (2012-01-01)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
by: Herring, N, et al.
Published: (2009)

Cabergoline: an effective treatment&nbsp;for conception in prolactinoma
by: Zahra Safdar, et al.
Published: (2022-09-01)

Prolactinoma - which patients react favorably to cabergoline medication?
by: Karatas Savas, et al.
Published: (2022-10-01)

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
by: Annabelle G Hayes, et al.
Published: (2023-01-01)

The efficacy of high-dose cabergoline treatment of prolactinomas resistant to standard doses: a clinical observation
by: Zilya A. Kalmykova, et al.
Published: (2019-09-01)

The course of pregnancy and delivery in patients with prolactinoma during treatment with cabergoline
by: Larisa Dzeranova, et al.
Published: (2016-11-01)

Increased Lipid Levels Improves after Treatment with Cabergolin in Patients with Prolactinoma
by: Mazhar Muslum Tuna, et al.
Published: (2015-03-01)

Profile of vitamin D in a cohort of physicians and diabetologists in Kolkata
by: Arjun Baidya, et al.
Published: (2012-01-01)

Binge Eating and Compulsive Buying During Cabergoline Treatment for Prolactinoma: A Case Report
by: Ana Carolina Correa e Castro, et al.
Published: (2022-05-01)

Effectiveness of Cabergoline in Reduction of Tumor Volume and Suppression of Prolactin in Treatment-Naive Prolactinomas and the Correlation of T2-weighted Signal Characteristics of Adenomas with Their Response to Treatment
by: Musadiq Adil Sheikh, et al.
Published: (2022-06-01)

Subarachnoid Hemorrhage Due to Rupture of an Intracavernous Carotid Artery Aneurysm Coexisting with a Prolactinoma under Cabergoline Treatment
by: Nobuyuki Akutsu, et al.
Published: (2014-03-01)

Operative treatment of cystic prolactinomas: a retrospective study
by: Weijie Su, et al.
Published: (2023-05-01)

Oxidative stress in hypothyroid patients and the role of antioxidant supplementation
by: Sumit Kumar Chakrabarti, et al.
Published: (2016-01-01)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the West Bengal cohort of the A 1 chieve study
by: Satinath Mukhopadhyay, et al.
Published: (2013-01-01)

Surgical Management of Giant Prolactinomas: A Descriptive Study
by: Michelle D. Lundholm, et al.
Published: (2023-01-01)

Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01)

Prolactinomas.
by: Grossman, A, et al.
Published: (1985)

CABERGOLINE IN PRACTICAL MAMMOLOGY
by: I. V. Vysotskaya, et al.
Published: (2016-12-01)

A clinical case of effective treatment of giant prolactinoma in patient with morbid obesity
Published: (2014-06-01)

PROLACTINOMAS - REPLY
by: Grossman, A, et al.
Published: (1985)

Treatment of Prolactinoma
by: Warrick J. Inder, et al.
Published: (2022-08-01)

Cabergoline in the Treatment of Peripartum Cardiomyopathy
by: James D. Fett
Published: (2016-08-01)

Prolactinomas e gravidez.
by: Manuela Carvalheiro, et al.
Published: (1985-08-01)

The use of cabergoline for treatment of syndrome of ovarian hyperstimulation
Published: (2012-12-01)

Treatment of prolactinomas with megavoltage radiotherapy.
by: Grossman, A, et al.
Published: (1984)

Treatment of prolactinomas with megavoltage radiotherapy.
by: Grossman, A, et al.
Published: (1984)

When to discontinue treatment of prolactinoma?
by: Wass, J
Published: (2006)

A case of giant prolactinoma and pituitary hemorrhage with the late recovery of pituitary function: A case report
by: Lakshmi P Menon, et al.
Published: (2023-07-01)

Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1
by: Naiara C. B. Dantas, et al.
Published: (2019-08-01)

Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
by: Sunita M C De Sousa
Published: (2023-01-01)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
by: Karavitaki, N, et al.
Published: (2013)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
by: Karavitaki, N, et al.
Published: (2013)

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
by: Ismail, I.S., et al.
Published: (1994)

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
by: Tobias J. Pfeffer, et al.
Published: (2023-02-01)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
by: Grossman, A, et al.
Published: (1986)

DICER1 mutation and pituitary prolactinoma
by: Cotton, E, et al.
Published: (2018)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
by: Grossman, A, et al.
Published: (1985)